Elevance Health Inc (ELV · NYSE)

ELV · MARKET VIEW

Market view · as of Sep 7, 2026

Revenue (TTM)
$201.11B
+1.4% YoY
Gross margin
26.0%
EPS (latest q)
$7.45
vs $6.18 est · beat
52-wk position
87.0%
-4.5% vs 52w high · +3.4% 1mo

Price (last ~year)

Elevance Health Inc. (ELV) posted a 13.1% year-over-year decline in earnings despite exceeding analyst estimates in each of the last four quarters. The company reported $201.11 billion in trailing twelve-month revenue, with the quarter ending June 30, 2026, contributing $50.47 billion in revenue and $1.46 billion in net income. The health benefits firm is currently navigating legal challenges regarding air ambulance claims and wage disputes while expanding its Carelon unit's clinical guidance.

Valuation

Market cap
$88.37B
P/E
18.02
PEG
1.357
P/B
2.004
P/S
0.439
Beta
0.696
Analyst target
$449.1

Quality & returns

Gross margin
26.0%
Operating margin
4.6%
Profit margin
2.5%
ROE
11.1%
ROA
3.8%

Price movement

Last
$407.50
1-month
+3.4%
3-month
+0.7%
RSI (14)
64
vs SMA200
+14.0%
52-wk position
87.0% -4.5% vs high

Quarterly trajectory

Revenue by quarter (oldest → newest)

QuarterRevenueOp incomeNet incomeEBITDA
2026-06-30$50.47B$2.06B$1.46B$2.10B
2026-03-31$50.18B$2.66B$1.76B$2.77B
2025-12-31$49.75B$581.0M$547.0M$987.0M
2025-09-30$50.71B$1.76B$1.19B$2.14B

Recent news

Sources this view read

  • fundamentals Company overview & valuation (Alpha Vantage OVERVIEW)
  • filing Quarterly financial statements (Alpha Vantage INCOME/BALANCE/CASH)
  • earnings Reported earnings history (Alpha Vantage EARNINGS)
  • prices Adjusted daily prices (Alpha Vantage TIME_SERIES_DAILY_ADJUSTED)

Other snapshots